OcuSciences, Inc.

OcuSciences is an ophthalmic imaging company developing the OcuMet Beacon, a rapid and non-invasive ocular imager that utilizes OcuMet autofluorescence technology for detecting and monitoring eye diseases. The FDA-cleared device employs state-of-the-art optics to provide ophthalmologists and optometrists with functional retinal imaging capabilities. The technology enables fast, automated assessment of ocular pathology through endogenous autofluorescence measurement, assisting clinicians in disease detection and monitoring for conditions such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma.